Science Explorer Back to mapMap
Discussion
Researcher · Institut Claudius Regaud · France

François Poumeaud

François Poumeaud publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies and HER2/EGFR in Cancer Research.

ORCID 0000-0002-4453-187X OpenAlex
World rank
#2,163,297
of 7,710,434 ranked researchers
Rank in France
#93,547
of 324,115
Works
29
Citations
246
Citations per work
8.5
h-index
9
i10-index 9Top 65% in Oncology
François Poumeaud

What does François Poumeaud research?

François Poumeaud's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 19 works · 65.0% of their workMedicine: 19 works · 65.0% of their workOncology: 8 works · 27.7% of their workPulmonary and Respiratory Medicine: 6 works · 20.5% of their workGenetics: 2 works · 7.2% of their workNeurology: 1 works · 4.8% of their workPathology and Forensic Medicine: 1 works · 4.8% of their workEverything else: 8 works · 27.8% of their workLife Sciences: 2 works · 7.2% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 7.2% of their workCancer Research: 2 works · 7.2% of their workTHEIR WORKFrançois Poumeaud29works
Life Sciences7%Health Sciences65%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1965.0%
  2. Everything else827.8%
    1. Biochemistry, Genetics and Molecular Biology27.2%
  1. 1Oncology28% of their works
  2. 2Pulmonary and Respiratory Medicine20% of their works
  3. 3Cancer Research7% of their works
  4. 4Genetics7% of their works
  5. 5Pathology and Forensic Medicine5% of their works
  6. 6Neurology5% of their works

Research topics

Which keywords describe François Poumeaud's research?

The keywords of their largest research topics: Metastatic Breast Cancer, Breast Cancer, Chemotherapy, CDK4/6 Inhibitors, Chemotherapy-Induced Peripheral Neuropathy, Palbociclib, Taxanes and Clinical Practice Guidelines.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Metastatic Breast Cancer202 topics
  2. Breast Cancer182 topics
  3. Chemotherapy112 topics
  4. CDK4/6 Inhibitors101 topic
  5. Chemotherapy-Induced Peripheral Neuropathy101 topic
  6. Palbociclib101 topic
  7. Taxanes101 topic
  8. Clinical Practice Guidelines82 topics
  9. HER281 topic
  10. Prognostic Factors83 topics
  11. Trastuzumab81 topic
  12. Radiotherapy72 topics
  13. Breast Tumours51 topic
  14. Gene Expression51 topic
  15. Chronic Lymphocytic Leukemia31 topic
  16. Genomic Aberrations31 topic
  17. Osteosarcoma31 topic
  18. Soft Tissue Sarcoma31 topic
  19. Glioblastoma21 topic
  20. Imatinib Mesylate21 topic
  21. Sunitinib21 topic
  22. Temozolomide21 topic

Where does François Poumeaud work?

François Poumeaud's main affiliation in the publication record is Institut Claudius Regaud, France.

How many publications and citations does François Poumeaud have?

OpenAlex counts 29 works and 246 citations for François Poumeaud, an h-index of 9, ranking #2,163,297 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about François Poumeaud. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.